C
GBT

Covestor’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Covestor’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6
Closed – – 2831
2022
Q3 		$0 Sell
6
-4
-40% -$221 ﹤0.01% 2840
2022
Q2 		$0 Sell
10
-3
-23% -$88 ﹤0.01% 2531
2022
Q1 		$0 Sell
13
-3
-19% -$90 ﹤0.01% 2553
2021
Q4 		$0 Buy
+16
New +$496 ﹤0.01% 2366

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Covestor's GBT Position: Q4 2022 in Review

Covestor sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 6 shares.

Covestor first reported a position in GBT in Q4 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Covestor reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Covestor sold 6 Global Blood Therapeutics, Inc. shares in Q4 2022.
  • Covestor first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
  • Covestor's Global Blood Therapeutics, Inc. position peaked at $0 in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Covestor's 13F filing for Q4 2022, filed 14 Feb 2023.